Nanopharm and FLUIDDA collaborate to enable alternative bioequivalence pathways for orally inhaled drug products To support generic drug companies in obtaining a market license for their orally inhaled drug products... View Article
The Pulmonary Vascular Research Institute (PVRI) yearly organizes a World Congress on Pulmonary Vascular Disease (PVD), this year from June 22-26 in Athens, Greece. The organization was established in 2006 to facilitate scientists, clinicians,... View Article
The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in... View Article
Fluidda will be present at the annual meeting of the ISHLT The ISHLT (The International Society for Heart and Lung transplantation) is pleased to announce that its 42nd Annual Meeting... View Article
Are you attending RSNA 2021? Visit the Fluidda Booth #4335 and learn all about Broncholab. Fluidda will introduce their new Medical Device Broncholab at the RSNA Conference. Broncholab enables accurate... View Article
FRI assessment of a fixed Triple Therapy (Bud/Gly/FF) and a fixed Dual Therapy (Gly/FF) in patients with COPD In a study presented as a poster at the virtual Chest conference, FRI was used... View Article
The Drug Delivery to the Lungs (DDL) Conference provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation. Fluidda is actively involved in... View Article
Prof. W. De Backer, Chairman of the Board of Fluidda nv, was interviewed at the ERS 2019 conference in Madrid about the insights that lead to the founding of the... View Article
From September 28 until October 2, Fluidda will exhibit at the annual conference of the European Respiratory Society (ERS) in Madrid, Spain. During this conference, Fluidda will present 7 posters on... View Article